Acrivon Therapeutics, Inc.
Total Trades
11
Buys
6
Sells
5
Largest Trade
$1M+
Insiders
6
Institutional Funds
31
Inst. Value
$1M+
Activist Filings
24
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Blume-Jensen Peter | President and CEO | BUY | $50K–$100K | 49K | $1.68 | Jan 16, 2026 |
| Levy Adam D. | CFO | BUY | $1K–$15K | 9K | $1.70 | Jan 16, 2026 |
| Devroe Eric | COO | BUY | $15K–$50K | 10K | $1.72 | Jan 15, 2026 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | SELL | $1M+ | 737K | $1.38 | May 1, 2025 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | SELL | $1M+ | 1.5M | $1.81 | Apr 29, 2025 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | BUY | $1M+ | 2.4M | $8.50 | Apr 15, 2024 |
| Chione Ltd | 10% Owner | SELL | <$1K | 16 | $12.93 | Jun 28, 2023 |
| Chione Ltd | 10% Owner | SELL | $15K–$50K | 2K | $12.14 | Jun 20, 2023 |
| Chione Ltd | 10% Owner | SELL | $50K–$100K | 6K | $12.29 | Jun 14, 2023 |
| Chione Ltd | 10% Owner | BUY | $1M+ | 400K | $12.50 | Nov 21, 2022 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 3.4M | $12.50 | Nov 21, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 31 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8.3M | $1M+ | SH |
| Sands Capital Alternatives, LLC | 2.1M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 634K | $1M+ | SH |
| VANGUARD GROUP INC | 587K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 581K | $1M+ | SH |
| UBS Group AG | 340K | $500K+ | SH |
| JANE STREET GROUP, LLC | 249K | $500K+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 166K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 119K | $100K–$500K | SH |
| STATE STREET CORP | 67K | $100K–$500K | SH |
| Squarepoint Ops LLC | 26K | $50K–$100K | SH |
| BARCLAYS PLC | 24K | $50K–$100K | SH |
| MARSHALL WACE, LLP | 18K | $15K–$50K | SH |
| Vermillion & White Wealth Management Group, LLC | 18K | $15K–$50K | SH |
| Schonfeld Strategic Advisors LLC | 16K | $15K–$50K | SH |
| CITIGROUP INC | 15K | $15K–$50K | SH |
| DIMENSIONAL FUND ADVISORS LP | 14K | $15K–$50K | SH |
| Point72 Asset Management, L.P. | 11K | $15K–$50K | SH |
| AAF Wealth Management, LLC | 11K | $15K–$50K | SH |
| BlackRock, Inc. | 11K | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Nov 21, 2025
4.9%
1.5M shares
SC 13G/A · Nov 14, 2025
4.9%
1.5M shares
Sands Capital Life Sciences Pulse Fund II, L.P.
SC 13G/A · Aug 13, 2025
6.8%
2.1M shares
SC 13G/A · Jun 4, 2025
0.0%
0 shares
SC 13G/A · May 15, 2025
6.0%
1.9M shares
SC 13G/A · May 2, 2025
9.9%
3.1M shares
SC 13G/A · Jul 11, 2024
12.5%
3.8M shares
SC 13G/A · Jul 11, 2024
17.3%
3.8M shares
SC 13G/A · Apr 15, 2024
17.4%
5.4M shares
SC 13D/A · Apr 11, 2024
27.1%
8.4M shares
SC 13G/A · Feb 14, 2024
7.4%
6 shares
SC 13G/A · Feb 14, 2024
13.6%
3.0M shares
Marshall Wace North America L.P.
SC 13G/A · Feb 14, 2024
2.7%
597K shares
Sands Capital Life Sciences Pulse Fund II, L.P.
SC 13G/A · Feb 13, 2024
7.4%
1.7M shares
SC 13D/A · Mar 30, 2023
22.0%
4.8M shares
Sands Capital Life Sciences Pulse Fund II, L.P.
SC 13G/A · Feb 14, 2023
7.9%
1.7M shares
SC 13G/A · Feb 14, 2023
14.4%
3.0M shares
Marshall Wace North America L.P.
SC 13G · Feb 14, 2023
5.9%
1.2M shares
SC 13G/A · Feb 14, 2023
7.8%
6 shares
SC 13D · Nov 28, 2022
23.1%
4.8M shares
SC 13G · Nov 28, 2022
18.5%
3.9M shares
Sands Capital Life Sciences Pulse Fund II, L.P.
SC 13G · Nov 25, 2022
7.9%
1.7M shares
SC 13G · Nov 21, 2022
7.8%
6 shares
SC 13G · Nov 18, 2022
14.4%
3.0M shares